Type of hormone therapy and risk of misclassification at mammography screening

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Type of hormone therapy and risk of misclassification at mammography screening. / Njor, Sisse H; Hallas, Jesper; Schwartz, Walter; Lynge, Elsebeth; Pedersen, Anette Tønnes.

In: Menopause , Vol. 18, No. 2, 01.02.2011, p. 171-177.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Njor, SH, Hallas, J, Schwartz, W, Lynge, E & Pedersen, AT 2011, 'Type of hormone therapy and risk of misclassification at mammography screening', Menopause , vol. 18, no. 2, pp. 171-177. https://doi.org/10.1097/gme.0b013e3181ea1fd5

APA

Njor, S. H., Hallas, J., Schwartz, W., Lynge, E., & Pedersen, A. T. (2011). Type of hormone therapy and risk of misclassification at mammography screening. Menopause , 18(2), 171-177. https://doi.org/10.1097/gme.0b013e3181ea1fd5

Vancouver

Njor SH, Hallas J, Schwartz W, Lynge E, Pedersen AT. Type of hormone therapy and risk of misclassification at mammography screening. Menopause . 2011 Feb 1;18(2):171-177. https://doi.org/10.1097/gme.0b013e3181ea1fd5

Author

Njor, Sisse H ; Hallas, Jesper ; Schwartz, Walter ; Lynge, Elsebeth ; Pedersen, Anette Tønnes. / Type of hormone therapy and risk of misclassification at mammography screening. In: Menopause . 2011 ; Vol. 18, No. 2. pp. 171-177.

Bibtex

@article{20391f70eab6493a996ccdf7118ad633,
title = "Type of hormone therapy and risk of misclassification at mammography screening",
abstract = "Current users of hormone therapy (HT) are known to have a lower accuracy of mammography screening than do never users. We studied whether the risk of misclassification depends on type of hormone, administration, regimen, and dose of the therapy.",
keywords = "Aged, Breast Neoplasms, Carcinoma, Denmark, Diagnostic Errors, Early Detection of Cancer, Female, Hormone Replacement Therapy, Humans, Mammography, Mass Screening, Middle Aged, Risk, Treatment Outcome",
author = "Njor, {Sisse H} and Jesper Hallas and Walter Schwartz and Elsebeth Lynge and Pedersen, {Anette T{\o}nnes}",
year = "2011",
month = "2",
day = "1",
doi = "10.1097/gme.0b013e3181ea1fd5",
language = "English",
volume = "18",
pages = "171--177",
journal = "Menopause",
issn = "1072-3714",
publisher = "Lippincott Williams & Wilkins",
number = "2",

}

RIS

TY - JOUR

T1 - Type of hormone therapy and risk of misclassification at mammography screening

AU - Njor, Sisse H

AU - Hallas, Jesper

AU - Schwartz, Walter

AU - Lynge, Elsebeth

AU - Pedersen, Anette Tønnes

PY - 2011/2/1

Y1 - 2011/2/1

N2 - Current users of hormone therapy (HT) are known to have a lower accuracy of mammography screening than do never users. We studied whether the risk of misclassification depends on type of hormone, administration, regimen, and dose of the therapy.

AB - Current users of hormone therapy (HT) are known to have a lower accuracy of mammography screening than do never users. We studied whether the risk of misclassification depends on type of hormone, administration, regimen, and dose of the therapy.

KW - Aged

KW - Breast Neoplasms

KW - Carcinoma

KW - Denmark

KW - Diagnostic Errors

KW - Early Detection of Cancer

KW - Female

KW - Hormone Replacement Therapy

KW - Humans

KW - Mammography

KW - Mass Screening

KW - Middle Aged

KW - Risk

KW - Treatment Outcome

U2 - 10.1097/gme.0b013e3181ea1fd5

DO - 10.1097/gme.0b013e3181ea1fd5

M3 - Journal article

C2 - 20729766

VL - 18

SP - 171

EP - 177

JO - Menopause

JF - Menopause

SN - 1072-3714

IS - 2

ER -

ID: 34117796